MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.
Tourlite Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the ...
Stocks rallied on Monday as investors digested fresh comments from top Fed officials and AI companies rebounded from last ...
Let's Talk Money! with Joseph Hogue, CFA on MSN

3 Stocks to Buy April 2021 for a Second Chance at Returns

Discover three stock picks for April 2021 in the energy and financials sectors! Capitalize on market dips and potential ...
Let's Talk Money! with Joseph Hogue, CFA on MSN

3 Stocks to Buy in May 2021 for Healthy Returns

Our 2021 stock portfolio is beating the market by 20% and I’ve found three stocks to buy in May to take it further. Don’t ...
U.S. stock futures rose Sunday, in hopes of building on Friday’s rebound, as investors await the start of the critical ...